MDCO News 24.55 The Medicines Company (MDCO)

New Post Public Reply Private Reply Replies (0) Message Board

Apr 17, 2014 at 6:43 PM

The Medicines Company (MDCO) 24.55 $MDCO

Downgrade Alert for Medicines Co (MDCO)
Comtex SmarTrend(R) - Thu Apr 17, 7:56AM CDT
Medicines Co (NASDAQ:MDCO) was downgraded from Outperform to Market Perform at Leerink today. The stock closed yesterday at $24.90 on volume of 692,000 shares, below average daily volume of 1.3 million. Medicines Co (NASDAQ:MDCO) has potential upside of 30.0% based on a current price of $24.90 and analysts' consensus price target of $32.38. The stock should find initial resistance at its 50-day moving average (MA) of $29.06 and further resistance at its 200-day MA of $33.06.

Biotech Stock Roundup: MannKind PDUFA Date Pushed Out, Alkermes Impresses with Data - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Apr 16, 9:07AM CDT
The selloff in the biotech sector continued with overall sentiment remaining bearish.

Medicines Co Has Returned 32.0% Since SmarTrend Recommendation (MDCO)
Comtex SmarTrend(R) - Tue Apr 15, 9:12AM CDT
SmarTrend identified a Downtrend for Medicines Co (NASDAQ:MDCO) on January 29th, 2014 at $36.13. In approximately 3 months, Medicines Co has returned 31.97% as of today's recent price of $24.58.

Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin
PR Newswire - Fri Apr 11, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Actavis plc (NYSE: ACT), The Medicines Company (NASDAQ: MDCO), Hospira, Inc. (NYSE: HSP), Horizon Pharma, Inc. (NASDAQ: HZNP), and Galectin Therapeutics Inc. (NASDAQ: GALT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Pharma Equities under Review -- Research on Mylan, Actavis, Hospira, and Medicines
PR Newswire - Thu Apr 10, 11:30AM CDT
On Wednesday, April 09, 2014, the NASDAQ Composite ended at 4,183.90, up 1.72%, the Dow Jones Industrial Average advanced 1.11% to 16,437.18, and the S&P 500 closed at 1,872.18, up 1.09%. The gains were broad based as eight out of 10 sectors ended the session in positive. The S&P 500 Health Care Sector Index finished the day at 673.27, up 2.11%, while the same has declined 2.01% in the last one month. Investor-Edge has initiated coverage on the following equities: Mylan Inc. (NASDAQ: MYL), Actavis PLC (NYSE: ACT), Hospira Inc. (NYSE: HSP) and The Medicines Co. (NASDAQ: MDCO). Free technical research on MYL, ACT, HSP and MDCO can be downloaded upon signing up at:

UPCOMING DEADLINE: Levi & Korsinsky, LLP Notifies Investors of Class Action Against THE MEDICINES COMPANY and Its Board of Directors and a Lead Plaintiff Deadline of April 22, 2014
Business Wire - Thu Apr 10, 11:10AM CDT
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of investors who purchased The Medicines Company ("Medicines" or the "Company"

(NasdaqGS:MDCO) securities between February 20, 2013 and February 12, 2014.

INVESTOR ALERT: Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Against The Medicines Company
Business Wire - Thu Apr 10, 9:32AM CDT
Glancy Binkow & Goldberg LLP reminds investors of The Medicines Company (NASDAQ:MDCO) that all purchasers of The Medicines Company securities between February 20, 2013 and February 12, 2014, inclusive (the "Class Period"

, have until April 22, 2014, to file a motion to be appointed as lead plaintiff in the shareholder lawsuit.

The Zacks Analyst Blog Highlights:MannKind, Cubist, Medicines Co., Amgen and Halozyme
PR Newswire - Thu Apr 10, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the MannKind (Nasdaq:MNKD-Free Report), Cubist (Nasdaq:CBST-Free Report), Medicines Co. (Nasdaq:MDCO-Free Report), Amgen (Nasdaq:AMGN-Free Report) and Halozyme (Nasdaq:HALO-Free Report).

Biotech Stock Roundup: MannKind Soars on Panel Vote, Halozyme Plunges on Safety Concerns - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Apr 09, 11:46AM CDT
Last week saw a couple of positive FDA panel votes as well as some disappointing data on experimental drugs.

The Medicines Company to Announce First Quarter 2014 Financial Results on Wednesday, April 23, 2014
Marketwire - Wed Apr 09, 9:11AM CDT
The Medicines Company (NASDAQ: MDCO) has scheduled its quarterly conference call for Wednesday, April 23 at 8:30 a.m. Eastern Time to discuss first quarter 2014 financial results, operational developments, and outlook for 2014.

Downtrend Call Working As Medicines Co Stock Falls 32.9% (MDCO)
Comtex SmarTrend(R) - Mon Apr 07, 4:51PM CDT
SmarTrend identified a Downtrend for Medicines Co (NASDAQ:MDCO) on January 29th, 2014 at $36.13. In approximately 2 months, Medicines Co has returned 32.91% as of today's recent price of $24.24.

Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in The Medicines Company of Class Action Lawsuit and Upcoming Deadline -- MDCO
GlobeNewswire - Mon Apr 07, 3:00AM CDT
Pomerantz LLP has filed a class action lawsuit against The Medicines Company ("Medicines" or the "Company"

(Nasdaq:MDCO) and certain of its officers. The class action, filed in United States District Court, District of New Jersey, and docketed under 2:33-av-00001, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Medicines securities between February 20, 2013 and February 12, 2014 both dates inclusive (the "Class Period"

. This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder.

The Medicines Co's Fibrocaps Under U.S. Review - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 04, 5:08PM CDT
The FDA accepted the biologic license application (BLA) for The Medicines Co.'s dry powder formulation of Fibrocaps.

Study Results, Stock Price Movements, Product Launches, and Updates on Court Case Trials - Analyst Notes on Medtronic, Alexion, DaVita, Thermo Fisher Scientific, and Medicines
PR Newswire - Fri Apr 04, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Medtronic, Inc. (NYSE: MDT), Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN), DaVita, Inc. (NYSE: DVA), Thermo Fisher Scientific, Inc. (NYSE: TMO), and Medicines Co. (NASDAQ: MDCO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

The Medicines Company announces FDA acceptance of BLA of its investigational hemostatic agent Fibrocaps
M2 - Fri Apr 04, 6:13AM CDT
Health care company The Medicines Company (NASDAQ:MDCO) revealed on Thursday that its biologic license application (BLA) for the investigational hemostatic agent Fibrocaps has been accepted for filing by the US Food and Drug Administration (US FDA).

Morning Movers in Biotech: Medicines Co., Omeros Corporation, Opko Health, Inc. and VIVUS, Inc.
George Budwell, The Motley Fool - Motley Fool - Thu Apr 03, 8:03AM CDT
Let's take a look at today's top stories in biotech and health care. Keep an eye out for The Medicines Company , Omeros Corp. , Opko Health and VIVUS, . FDA accepts The Medicines Company's Biologic License Application for Fibrocaps ...

FDA Accepts the Filing of The Medicines Company's US Biologic License Application for Fibrocaps Hemostatic Agent
Marketwire - Thu Apr 03, 6:01AM CDT
The Medicines Company (NASDAQ: MDCO) today announced that the U.S. Food and Drug Administration (FDA) has accepted the filing of a biologic license application (BLA) for the investigational hemostatic agent Fibrocaps, a dry powder formulation of fibrinogen and thrombin being developed to aid in hemostasis during surgery, where control of mild or moderate bleeding by conventional means is ineffective or impractical. The FDA action date (PDUFA date) for Fibrocaps is January 31, 2015.

The Medicines Co. Falls on Angiomax Woes - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 02, 4:30PM CDT
The U.S. District Court of Delaware found that Hospira Inc.'s generic version of The Medicines Co.'s Angiomax does not infringe the patents.

Today's Dead Cat Bounce Stock: Medicines Company (MDCO)
at The Street - Wed Apr 02, 10:57AM CDT
Trade-Ideas LLC identified Medicines Company (MDCO) as a "dead cat bounce" (down big yesterday but up big today) candidate

Biotech Stock Roundup: Biogen Drug Approved, Exelixis Tumbles on Study Update - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Apr 02, 9:43AM CDT
Biotech companies continued to witness a decline in share prices last week.

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Tragedy Highlights Need for E-bike Safety Overhaul

A Dire Wake-Up Call in the East Village We're staring hard at a heartbreaking mess in the East Village. A 15-year-old girl lost her life while riding an electric Citi Bike, hit by an industrial truck. Let's not dance around it—this is a gut punch, the kind you never want to ever hear about, and one that comes with a bitter flavor of 'what if?' Age Verification: A...

Flying Car Regulatory Sandbox Begins in UAE

Pioneering Flying Cars in the Desert In a move that seems right out of a science fiction screenplay, ARIDGE—the bigwig of flying cars from Asia—has taken a giant leap. They’ve cozied up with the UAE, locking arms to cook up the world's first regulatory sandbox for personal flying cars. Now, don’t laugh—sandbox isn't just for toddlers. It’s the playground where...

Why Liver Nurture Taps into Health Sector Trends

Liver Wellness: A Sector on the Rise Remember when everyone was all about heart health and cholesterol levels? Seems like these days, folks have shifted their focus a bit south—right to the liver. It's no surprise, really. With our modern diet and lifestyle choices squeezing the life out of this hard-working organ, people are on the hunt for ways to give it the TLC it...

Papa John's Faces Class Action Over Misleading Info

Trouble Brewing for Papa John's Investors Rolling the dice in the stock market sometimes feels like playing the lottery, doesn't it? This time around, it's Papa John's (NASDAQ: PZZA) serving up a slice of turmoil for its investors. The pizza chain's got itself tangled in a class-action lawsuit, and it's the shareholders who're left with a bitter taste. Investors Cry Foul...

BarrelPick.com Launches for Bourbon Aficionados

Just when you think you've seen all the ways to enjoy bourbon, along comes BarrelPick.com with a tantalizing new proposition. They're throwing down the gauntlet for bourbon lovers everywhere by letting you buy an entire barrel, let it sit around for a bit, watch it mature, and then call the shots on when it finally sees the light of day in a bottle. Talk about skipping...

Med Spa Visits: Key Insights from Lindsey Smith

Moving Beyond the Fear Factor Stepping into a med spa for the first time can be nerve-wracking, especially if you're unsure of what to expect. Lindsey Smith, an expert from Flawless Med Spa in Bryant, Arkansas, knows just how critical it is to navigate this terrain with clarity. Her approach emphasizes building a foundation of trust and understanding from the get-go. Fear...

Qatar Foundation Spurs Sport-Driven Empowerment Moves

Here we go, diving into the serious talk of the moment: sports pushing boundaries to uplift society's underdogs. Envision yourself in the halls of Wilton Park, where the thinkers, the dreamers, and the doers convened in the name of change. Qatar Foundation ain't just sitting pretty; they're championing the cause to harness sport for impactful social threads across the...

USPS Rolls Out Christmas Cookie Stamps Nationwide

USPS Delivers Nostalgia with Cookie-Themed Stamps Let's talk stamps, folks. The U.S. Postal Service has rolled out its newest Christmas Cookies Forever stamps, bringing a dash of sugary nostalgia to mailboxes nationwide. The release was celebrated at the Smithsonian National Postal Museum, spotlighting a tradition as sweet as the sugar cookies themselves. These aren't...

Insta360 Expands with Times Square Flagship Store

Insta360 Times Square Opening Marks Bold Expansion I dropped by Times Square today, and what do I see? Insta360 planting its flag right in the heart of New York City. Now, this isn't your run-of-the-mill grand opening—it’s the first flagship store outside of Asia, and it screams of big ambitions. Nestled at 1515 Broadway, the store is smack in the middle of one of the...